Ponec R J, Saunders M D, Kimmey M B
Division of Gastroenterology, University of Washington Medical Center, Seattle 98195, USA.
N Engl J Med. 1999 Jul 15;341(3):137-41. doi: 10.1056/NEJM199907153410301.
Acute colonic pseudo-obstruction -- that is, massive dilation of the colon without mechanical obstruction -- may develop after surgery or severe illness. Although it may resolve with conservative therapy, colonoscopic decompression is sometimes needed to prevent ischemia and perforation of the bowel. Uncontrolled studies have suggested that neostigmine, may be an effective treatment.
We studied 21 patients with acute colonic pseudo-obstruction. All had abdominal distention and radiographic evidence of colonic dilation, with a cecal diameter of at least 10 cm, and had had no response to at least 24 hours of conservative treatment. We randomly assigned 11 to receive 2.0 mg of neostigmine intravenously and 10 to receive intravenous saline. A physician who was unaware of the patients' treatment assignments recorded clinical response (defined as prompt evacuation of flatus or stool and a reduction in abdominal distention), abdominal circumference, and measurements of the colon on radiographs. Patients who had no response to the initial injection were eligible to receive open-label neostigmine three hours later.
Ten of the 11 patients who received neostigmine had prompt colonic decompression, as compared with none of the 10 patients who received placebo (P<0.001). The median time to response was 4 minutes (range, 3 to 30). Seven patients in the placebo group and the one patient in the neostigmine group without an initial response received open-label neostigmine; all had colonic decompression. Two patients who had an initial response to neostigmine required colonoscopic decompression for recurrence of colonic distention; one eventually underwent subtotal colectomy. Side effects of neostigmine included abdominal pain, excess salivation, and vomiting. Symptomatic bradycardia developed in two patients and was treated with atropine.
In patients with acute colonic pseudo-obstruction who have not had a response to conservative therapy, treatment with neostigmine rapidly decompresses the colon.
急性结肠假性梗阻——即结肠无机械性梗阻的大量扩张——可在手术后或患重病后发生。尽管它可能通过保守治疗得以缓解,但有时需要结肠镜减压以防止肠缺血和穿孔。非对照研究提示,新斯的明可能是一种有效的治疗方法。
我们研究了21例急性结肠假性梗阻患者。所有患者均有腹胀及结肠扩张的影像学证据,盲肠直径至少10 cm,且对至少24小时的保守治疗无反应。我们将11例患者随机分配接受静脉注射2.0 mg新斯的明,10例患者接受静脉注射生理盐水。一名不知道患者治疗分配情况的医生记录临床反应(定义为迅速排出气体或粪便以及腹胀减轻)、腹围和X线片上结肠的测量值。对初次注射无反应的患者有资格在3小时后接受开放标签的新斯的明治疗。
接受新斯的明治疗的11例患者中有10例迅速出现结肠减压,而接受安慰剂治疗的10例患者均未出现(P<0.001)。反应的中位时间为4分钟(范围3至30分钟)。安慰剂组的7例患者和新斯的明组中初次无反应的1例患者接受了开放标签的新斯的明治疗;所有患者均出现结肠减压。2例对新斯的明初次有反应的患者因结肠扩张复发需要结肠镜减压;1例最终接受了结肠次全切除术。新斯的明的副作用包括腹痛、唾液分泌过多和呕吐。2例患者出现症状性心动过缓并接受了阿托品治疗。
在对保守治疗无反应的急性结肠假性梗阻患者中,新斯的明治疗可迅速使结肠减压。